Eosinophilic disorders in children

Current Allergy and Asthma Reports

Volumn 6, Issue 6, 2006, Pages 475-482

  Wagelie Steffen, Amy ^a   Aceves, Seema S ^a  

^a RADY CHILDREN'S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BUDESONIDE; CORTICOSTEROID; FLUTICASONE PROPIONATE; GLUCOCORTICOID; HYDROXYUREA; IMATINIB; INTERLEUKIN 5 ANTIBODY; MEPOLIZUMAB; MERCAPTOPURINE; OMALIZUMAB; PREDNISONE; PROTEIN TYROSINE KINASE INHIBITOR; VINCRISTINE;

ADRENAL SUPPRESSION; ALLERGIC ASTHMA; ATOPY; BRONCHOPULMONARY ASPERGILLOMA; CATARACT; CHILD; CHILDHOOD DISEASE; CLINICAL TRIAL; CORTICOSTEROID INDUCED OSTEOPOROSIS; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; ELEMENTAL DIET; EOSINOPHILIA; EOSINOPHILIC ESOPHAGITIS; EOSINOPHILIC GASTROENTERITIS; ESOPHAGUS CANDIDIASIS; GROWTH DISORDER; HUMAN; HYPEREOSINOPHILIC SYNDROME; HYPERIMMUNOGLOBULINEMIA E; IMMUNE DEFICIENCY; LEUKOCYTE ACTIVATION; LEUKOCYTE MIGRATION; NONHUMAN; OMENN SYNDROME; PATHOGENESIS; PATHOPHYSIOLOGY; REVIEW; SYSTEMIC DISEASE; TISSUE INJURY; TISSUE REPAIR; TREATMENT PLANNING;

ASTHMA; CHILD; DERMATITIS, ATOPIC; EOSINOPHILS; ESOPHAGITIS; HUMANS; HYPEREOSINOPHILIC SYNDROME; INTERLEUKIN-5; PROTEIN KINASE INHIBITORS;

EID: 33750314695     PISSN: 15297322     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11882-006-0024-5     Document Type: Review

References (51)

1. Rothenberg ME, Hogan SP: The Eosinophil. Annu Rev Immunol 2006, 24:147-174.
2. Kato M, Kephart GM, Talley NJ, et al.: Eosinophil infiltration and degranulation in normal human tissue. Anat Rec 1998, 3:418-425.
3. Martinez-Moczygemba M, Huston DP: Biology of common beta receptor-signaling cytokines: IL-3, IL-5, and GM-CSF. J Allergy Clin Immunol 2003, 112:653-665.
4. Wardlaw AJ: Molecular basis for selective eosinophil trafficking in asthma: a multistep paradigm. J Allergy Clin Immunol 1999, 104:917-926.
5. Rothenberg ME: Eosinophilic gastrointestinal disorders (EGID). J Allergy Clin Immunol 2003, 113:11-28.
6. Gleich GJ, Leiferman KM: The hypereosinophilic syndromes: still more heterogeneity. Curr Opin Immunol 2005, 6:679-684.
7. Weller PF: Eosinophilia and eosinophil related disorders. In Middleton's Allergy Principles and Practice. Edited by Adkinson NF, Yunginger JW, Busse WW, et al.: Philadelphia: Mosby; 2003:1105-1126.
8. Foster PF, Sankary HN, Hart M, et al.: Blood and graft eosinophilia as predictors of rejection in human liver transplantation. Transplantation 1989, 47:72-74.
9. Flood-Page P, Menzies-Gow A, Phipps S, et al.: Anti-IL-5 treatment reduces deposition of ECM proteins in the bronchial subepithelial basement membrane of mild atopic asthmatics. J Clin Invest 2003, 112:1029-1036.
10. de Almeida MB, Bussamra MH, Rodrigues JC: Allergic bronchopulmonary aspergillosis in paediatric cystic fibrosis patients. Paediatr Respir Rev 2006, 7:67-72.
11. Hardy WR, Anderson RE: The hyperesoinophilic syndromes. Ann Intern Med 1968, 68:1220-1229.
12. Chusid MJ, Dale DC, West BD, et al.: The hypcresoinophilic syndrome: analysis of fourteen cases with review of the literature. Medicine 1975, 54:1-24.
13. Klion AD, Bochner BS, Gleich GJ, et al.: Approaches to the treatment of hypereosinophilic syndrome: a workshop summary report. J Allergy Clin Immunol 2006, 117:1292-1302.
14. Katz HT, Haque J, Hsieh F: Pediatric hypereosinophilic syndrome (HES) differs from adult HES. J Pediatr 2005, 1146:134-136.
15. Cools J, DeAngelo DJ, Gotlib J, et al.: A novel tyrosine kinase created by the fusion of the PDGFRA and FIP1L1 genes is a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome. N Engl J Med 2003, 348:1201-1214.
16. Yamada Y, Rothenberg ME, Lee AW, et al.: The FIP1L1-PDGFRA fusion gene cooperates with IL-5 to induce murine hypereosinophilic syndrome (HES)/ chronic eosinohilic leukemia (CEL)-like disease. Blood 2006, 107:4071-4079.
17. Rives S, Alcorta I, Toll T: Idiopathic hypereosinophilic syndrome in children: report of a 7-year-old boy with FIP1L1-PDGFRA rearrangement. J Pediatr Hematol Oncol 2005, 27:663-665.
18. Wallen N, Kita H, Weiler D, et al.: Glucocorticoids inhibit cytokine mediated eosinophil survival. J Immunol 1991, 147:3490-3495.
19. Schandene L, Roufousse F, deLavareille A, et al.: Interferon alpha prevents spontaneous apoptosis of clonal Th2 cells associated with chronic hypereosinophilia. Blood 2000, 96:4285-4292.
20. Chehade M, Magid MS, Mofidi S, et al.: Allergic eosinophilic gastroenteritis with protein losing enteropathy: intestinal pathology, clinical course and long-term follow-up. J Pediatr Gastroenterol Nutr 2006, 42:516-521.
21. Aceves SS, Newbury RO, Dohil R, et al.: Distinguishing eosinophilic esophagitis in pediatric patients: clinical, endoscopic and histologic features of an emerging disorder. J Clin Gastroenterol 2006, In press.
22. Straumann A, Simon HU: Eosionphilic esephagitis: escalating epidemiology? J Allergy Clin Immunology 2005, 115:419-419.
23. Noel RJ, Putnam PE, Rothenberg ME: Eosinophilic esophagitis. N Engl J Med 2004, 351:940-941.
24. Ruchelli E, Wenner W, Voytek T, et al.: Severity of esophageal cosinophilia predicts response to conventional gastroesophageal reflux therapy. Pediatr Dev Patbol 1999,2:15-18.
25. Liacouras CA: Eosinophilic esophagitis: treatment in 2005. Curr Opin Gastroenterol 2006, 22:147-152.
26. Mueller S, Aigner T, Neureiter D, et al.: Eosinophil infiltration and degranulation in esophageal mucosa from adult patients with eosinophilic esophagitis. A retrospective comparative pathologic biopsy study. J Clin Pathol 2006, In press.
27. Straumann A, Kristl J, Conus S, et al.: Cytokine expression in healthy and inflamed mucosa: probling the role of eosinophils in the digestive tract. Inflamm Bowel Dis 2005, 11:720-726.
28. Noel RJ, Putnam PE, Collins MH, et al.: Clinical and immunopathologic effects of swallowed fluticasone for eosinophilic esophagitis. Clin Gastroenterol Hepatol 2004, 2:568-75.
29. Steiner S, Kernek KM, Fitzgerald JF: Severity of basal ccll hyperplasia differs in reflux versus eosinophilic esophagitis. J Pediatr Gastroenterol Nutr 2006, 42:506-509.
30. Ravelli AM, Villanacci V, Ruzzenenti N et al.: Dilated intercellular spaces: a major morphological feature of esophagitis. J Pediatr Gastroenterol Nutr 2006, 42:510-515.
31. Fox VL, Nurko S, Furuta GT. Eosinophilic esophagitis: It's not just kid's stuff. Gatrointest Endosc 2002, 56:260-270.
32. Straumann A, Spichtin HP, Grize L, et al.: Natural history of primary eosinophilic esophagitis: a follow-up of 30 adult patients for up to 11.5 years. Gastroenterology 2003, 125:1660-1669.
33. Orenstein SR, Shalaby TM, Di Lorenzo C, et al.: The spectrum of pediatric eosinophilic esophagitis beyond infancy: a clinical series of 30 children. Am J Gastroenterol 2000, 95:1422-1430.
34. Guajardo JR, Plotnick LM, Fende JM, et al.: Eosinophil-associated gastrointestinal disorders: a world-wide-web based registry. J Pedatr 2002, 141:576-81.
35. Blanchard C, Wang N, Stringer KF, et al.: Eotaxin-3 and a uniquely conserved gene-expression profile in eosinophilic esophagitis. J Clin Invest 2006, 116:536-547.
36. Kelly KJ, Lazenby AJ, Rowe PC, et al.: Eosinophilic esophagitis attributed to gastroesophageal reflux: improvement with an amino acid-based formula. Gastroenterology 1995, 109:1503-1512.
37. Spergel JM, Beausoleil JL, Mascarenhas M, et al.: The use of skin prick tests and patch tests to identify causative foods in eosinophilic esophagitis. J Allergy Clin Immunol 2002, 109:363-368.
38. Teitelbaum JE, Fox VL, Twarog FJ, et al.: Eosinophilic esophagitis in children: immunopathological analysis and response to fluticasone propionate. Gastroenterology 2002, 122:1216-1225.
39. Simon D, Marti H, Heer P, et al. Eosinophilic esophagitis is frequently associated with IgE-mediated allergic airway disease. J Allergy Clin Immunol 2005, 115:1090-1092.
40. Fogg MJ, Ruchelli E, Spergel JM: Pollen and eosinophilic esophagitis. J Allergy Clin Immunol 2003, 112:796-797.
41. Onbasi K, Sin AZ, Doganavsargil B, et al.: Eosinophil infiltration of the oesophageal mucosa in patients with pollen allergy during the season. Clin Exp Allergy 2005,35:1423-1431.
42. Straumann A, Bauer M, Fischer B, et al.: Idiopathic eosinophilic esophagitis is associated with a T(H)2-type allergic inflammatory response. J Allergy Clin Immunol 2001, 108:954-961.
43. Gupta SK, Fitzgerald JF, Kondratyuk T, et al.: Cytokine expression in normal and inflamed esophageal mucosa: a study into the pathogenesis of eosinophilic esophagitis. J Pediatr Gastroenterol Nutr 2006, 42:22-26.
44. Gupta SK, Peters-Golden M, Fitzgerald JF, et al.: Cysteinyl leukotriene levels in esophageal mucosal biopsies of children with eosinophilic inflammation: are they all the same? Am J Gastroenterol 2006, 101:1125-1128.
45. Akei HS, Mishra A, Blanchard C, et al.: Epicutaneous antigen exposure primes for experimental eosinophilic esophagitis in mice. Gastroenterology 2005, 129:985-994.
46. Faubion WA Jr, Perrault J, Burgart LJ, et al.: Treatment of eosinophilic esophagitis with inhaled corticosteroids. J Pediatr Gastroenterol Nutr 1998, 27:90-93.
47. Konikoff MR, Noel RJ, Blanchard C, et al.: A randomized double-blind placebo-controlled trial of fluticasone propionate for pediatric eosinophilic esophagitis. Gastroenterology, In press.
48. Aceves SS, Dohil R, Newbury RO, et al.: Topical viscous budesonide suspension for treatment of eosinophilic esophagitis. J Allergy Clin Immunol 2005, 116:705-706.
49. Liacouras CA, Spergel JM, Ruchelli E, et al.: Eosinophilic esophagitis: a 10-year experience in 381 children. Clin Gastroenterol Hepatol 2005, 3:1198-1206.
50. Foroughi S, Mannon PJ, Bernardino LB, et al.: Pilot study of omalizumab in eosinophilic gastroenteritis. J Allergy Clin Immunol 2006, 117:S304.
51. Garrett JK, Jameson SC , Thomson B, et al.: Anti-iuterleukin-5 (mepolizumab) therapy for hypereosinophilic syndromes. J Allergy Clin Immunol 2004, 113:115-119.